Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Edwards

Showing results (931-940 of 1,259) with videos related to

Pageof 126
Sort By:
Death Studies|July 29, 2025
Breaking the silence: A systematic review of methodology and findings of studies on bereavement among adults with intellectual and developmental disabilitiesLuz M Garcini, Kathryn O Gonzalez, Ling DeBellis, et al.
Chemical Science|June 4, 2021
Facile <i>in situ</i> reductive synthesis of both nitrogen deficient and protonated g-C<sub>3</sub>N<sub>4</sub> nanosheets for the synergistic enhancement of visible-light H<sub>2</sub> evolutionWeisong Li, Zheng Guo, Litong Jiang, et al.
International Journal of Molecular Sciences|February 13, 2025
Cardiac Tyrosine 97 Phosphorylation of Cytochrome <i>c</i> Regulates Respiration and ApoptosisPaul T Morse, Vignesh Pasupathi, Susanna Vuljaj, et al.
Journal of Medicinal Chemistry|September 5, 2003
5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulatorsLin Zhi, Christopher M Tegley, Barbara Pio, et al.
Cancer Immunology, Immunotherapy : CII|May 23, 2015
Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer modelJyothi Thyagabhavan Mony, Lixin Zhang, Tianzhou Ma, et al.
Frontiers in Oncology|June 7, 2021
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort StudyHelga Tryggvadottir, Emma Sandén, Sofie Björner, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitorsDanielle K Wiener, Alice Lee-Dutra, Scott Bembenek, et al.
Gynecologic Oncology|August 12, 2017
Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight lossFaina Linkov, Sharon L Goughnour, Tianzhou Ma, et al.
Cancer Research|August 3, 2007
Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinomaShuang Wei, Ilona Kryczek, Robert P Edwards, et al.
Brachytherapy|April 20, 2012
High-dose-rate interstitial computed tomography-based brachytherapy for the treatment of cervical cancer: early resultsNeeta Kannan, Sushil Beriwal, Hayeon Kim, et al.
Pageof 126

Showing results (931-940 of 1,259) with videos related to

Sort By:
Pageof 126
Death Studies|July 29, 2025
Breaking the silence: A systematic review of methodology and findings of studies on bereavement among adults with intellectual and developmental disabilitiesLuz M Garcini, Kathryn O Gonzalez, Ling DeBellis, et al.
Chemical Science|June 4, 2021
Facile <i>in situ</i> reductive synthesis of both nitrogen deficient and protonated g-C<sub>3</sub>N<sub>4</sub> nanosheets for the synergistic enhancement of visible-light H<sub>2</sub> evolutionWeisong Li, Zheng Guo, Litong Jiang, et al.
International Journal of Molecular Sciences|February 13, 2025
Cardiac Tyrosine 97 Phosphorylation of Cytochrome <i>c</i> Regulates Respiration and ApoptosisPaul T Morse, Vignesh Pasupathi, Susanna Vuljaj, et al.
Journal of Medicinal Chemistry|September 5, 2003
5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulatorsLin Zhi, Christopher M Tegley, Barbara Pio, et al.
Cancer Immunology, Immunotherapy : CII|May 23, 2015
Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer modelJyothi Thyagabhavan Mony, Lixin Zhang, Tianzhou Ma, et al.
Frontiers in Oncology|June 7, 2021
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort StudyHelga Tryggvadottir, Emma Sandén, Sofie Björner, et al.
Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitorsDanielle K Wiener, Alice Lee-Dutra, Scott Bembenek, et al.
Gynecologic Oncology|August 12, 2017
Changes in inflammatory endometrial cancer risk biomarkers in individuals undergoing surgical weight lossFaina Linkov, Sharon L Goughnour, Tianzhou Ma, et al.
Cancer Research|August 3, 2007
Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinomaShuang Wei, Ilona Kryczek, Robert P Edwards, et al.
Brachytherapy|April 20, 2012
High-dose-rate interstitial computed tomography-based brachytherapy for the treatment of cervical cancer: early resultsNeeta Kannan, Sushil Beriwal, Hayeon Kim, et al.
Pageof 126